Vaxcyte Inc.
PCVX | NASDAQ
$58.97
+$0.05 (+0.08%)
Sep 22, 2026, 12:18 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -8.20 | -21.54 | -15.17 | -13.94 | -12.33 | -8.95 |
PEG Ratio | -0.17 | 2.62 | -0.75 | -0.18 | 0.35 | 0.11 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.34 | 3.02 | 4.92 | 3.26 | 4.35 | 2.27 |
P/FCF Ratio | -9.38 | -21.02 | -16.73 | -17.63 | -9.65 | -16.43 |
P/OCF Ratio | -9.58 | -22.06 | -20.56 | -18.24 | -10.18 | -16.84 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.09 | 0.02 | 0.02 | 0.02 | 0.06 | n/a |
Quick Ratio | 7.91 | 12.75 | 7.54 | 23.26 | 8.93 | 8.30 |
Current Ratio | 7.91 | 12.75 | 7.54 | 23.26 | 8.93 | 8.30 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -116.13K | -14.81K | -12.8K |
Return on Equity | -28.55% | -14.03% | -32.43% | -23.44% | -35.24% | -25.80% |
Return on Assets | -25.17% | -13.21% | -28.57% | -22.21% | -30.86% | -22.71% |
Return on Invested Capital | -32.45% | -16.87% | -36.86% | -23.91% | -34.45% | -25.89% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove PCVX